Picture of Opus Genetics logo

IRD — Opus Genetics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapMomentum Trap

Brief: Opus Genetics Announces Updates On Opgx-Lca5 Clinical Program

Feb 18 (Reuters) - Opus Genetics Inc  IRD.O :
    * OPUS GENETICS ANNOUNCES UPDATES ON OPGX-LCA5 CLINICAL
PROGRAM
    * OPUS GENETICS INC: FDA MEETING SCHEDULED IN MARCH 2025 TO
DISCUSS PHASE 3 TRIAL DESIGN AND REGISTRATIONAL ENDPOINTS FOR
OPGX-LCA5
    * OPUS GENETICS INC: INITIAL DATA ON COHORT ANTICIPATED BY
Q3 2025

Source text:  ID:nGNX96nTcP 
Further company coverage:  IRD.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Opus Genetics

See all news